The BioSymetrics leadership team possesses significant expertise and professional experience in data science, medicine, and healthcare technology. Our solutions are underpinned by cross-disciplinary capabilities in machine learning, predictive analytics, big data, bioinformatics, computational biology, advanced image processing, and health IT.
Gabriel Musso, PhD
Chief Scientific Officer, Gabe@BioSymetrics.com
Babak Afshin-Pour, PhD
VP Technology, Babak@BioSymetrics.com
Victoria Catterson, PhD
Principal Data Scientist, Victoria@BioSymetrics.com
VP Business Development, Wendy@BioSymetrics.com
Wendy is responsible for managing and leading corporate deals and collaborations for Augusta™, our biomedical machine learning (ML) software platform. She has extensive experience in biopharmaceutical and health technology cross-functional team leadership, and has led several early-stage R&D and licensing deals. As co-founder of an oncology biotech formed from targeted cancer compounds developed at Duke University Medical Center, she managed all aspects of corporate development, business planning, BD and marketing. Prior to BioSymetrics, she consulted on enterprise IT and HIE projects; served as a Director in Clinical Quality and Outcomes at Inovalon Inc., a data analytics firm; and was a Product Manager in sales and marketing at Amgen. Wendy earned her M.B.A. from Kellogg at Northwestern University, and B.A. from Duke University.